Virco is a research-driven biotech company with headquarters in Belgium (Virco BVBA) and U.S. offices in New Jersey and North Carolina (Virco Lab, Inc.). Virco is a pioneer in the field of HIV-1 drug resistance testing, and is expanding its focus on diagnostic tools for other viral diseases. The company's mission is to enhance the clinical management of patients suffering from HIV-1 and other infectious diseases, and to improve their quality of life.
Virco's product portfolio currently includes the Antivirogram ® , an HIV-1 phenotyping assay, and virco ® TYPE HIV-1 . virco ® TYPE HIV-1 is a unique and proprietary approach to predict the virus' susceptibility to antiretroviral drugs from the genotype and uses the world's largest HIV-1 resistance database. Virco has also developed a software program, vircoNET TM , which allows the easy and secure transfer of data and test reports between Virco and the customers using the Internet as a communications platform.
This site is published by Johnson & Johnson Pharmaceutical Services, L.L.C., which is solely responsible for its contents.
This page was last modified on Apr 23 2008 at 10:41:22 EDT .
